Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma

Fig. 1

Expression level of LGALS3 gene in different tumors. (A) The expression of the LGALS3 gene in different cancers or specific cancer subtypes was assessed by TIMER2 (data from TCGA). (B) For the type of LAML, DLBC, THYM, and UCS in the TCGA database, the normal control samples of the GTEx database were included as controls. (C) The expression level of LGALS3 protein between normal tissue and primary tissue of clear cell RCC, GBM, LIHC, breast cancer, colon cancer, HNSC, LUAD, LUSC, and UCEC analyzed by CPTAC dataset. *p value < 0.05; **p value < 0.01; ***p value < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us